glp 1 agonist vs analog DPP4 Inhibitors GLP-1 Agonists | June 2021 | Clinical Corner Science Behind GLP 1 GIP

Its dual GLP-1/glucagon action also improves liver fat metabolism, making it especially promising for patients with obesity and liver-related conditions like MASH

These neurons project to various brain regions involved in energy balance and reward, including the hypothalamus and VTA

Like pancreatic -cells, the intestinal L-cells secrete PGDPs simultaneously and in equimolar concentrations

Furthermore, exendin-4 administration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in vivo animal model of PD has been shown to inhibit microglial activation thereby minimizing the loss of dopaminergic neurons in the pars compacta of the substantia nigra and the striatum [78]

Kennedy has worked in a variety of patient care settings: from operating room pharmacy, inpatient neurology, inpatient psychiatry, to community pharmacy

With this performance, GLP-1 receptor agonists have the audience rolling in the aisles (and shedding pounds!)